Golden Lee Scott bought CVKD
December 2, 2025 · Form 4 insider transaction
Golden Lee Scott bought 5,000 shares of Cadrenal Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$0.00
Total value
N/A
InsiderGolden Lee Scott
RoleOfficer
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateDecember 2, 2025
Filing dateDecember 3, 2025
Shares owned after5,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of options to purchase 5,000 shares of common stock, which shall vest 1/3 on January 1, 2027 and thereafter pro rata on a monthly basis over 24 months, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant.